https://www.marketscreener.com/quote/stock/SANOFI-4698/news/SANOFI-Effect-of-Genzyme-s-LEMTRADA-Maintained-in-Patients-Beyond-Two-Year-Pivotal-MS-Studies-16565612/?utm_source=telegram&utm_medium=social&utm_campaign=share